The diagnosis of liver cancer is generally performed by imaging techniques, such as ultrasonography, computed tomography and magnetic resonance tomography, in combination with the dosage of plasmatic alpha-fetoprotein (AFP) and histological analysis of tissue biopsies [7]. This evidence concerns the gene AFP and liver cancer.